|
|
|
 |
|
 |
Innovative R&D
Kamada's research and development (R&D) is carried out by highly-qualified staff with the knowledge, skills and experience required for delivering innovative solutions. This has enabled the company to earn a number of patents and an Orphan Drug Designation (ODD) status for several drugs in development.
Kamada’s human strength is complemented by its intellectual property. The company is also engaged in joint R&D programs combining our excellent R&D capabilities with those of our partners, towards the creation of new pharmaceuticals.
Kamada's various R&D methods utilize the company’s two main assets:
 |
Proprietary knowledge, skills and expertise |
|
cGMP-approved, state-of-the-art manufacturing facility and laboratory |
Kamada is interested in exploring the R&D possibilities presented by our unique know-how and outstanding abilities in protein purification (from Fr IV, IV-1 pastes and hyperimmune plasma). We can also adapt and develop our chromatography technology to process a variety of other manufacturers’ raw materials.
Regulatory Affairs
Kamada’s team includes managers with extensive and proven experience in drug development and registration in the U.S., Israel and other countries. Their expertise translates into an ability to successfully register Kamada’s products world-wide.
|
|
|
|
|
More
|
|
